• Pharma
  • October 29, 2022
  • 138 views
NPPA Panel Rejects Intas’ Application For Exemption Of Clozapine Extended Release Capsules

New Delhi : The expert panel of National Pharmaceutical Pricing Authority (NPPA) has once again rejected the application by Intas Pharmaceuticals Ltd for exemption from the provisions of Drug Price…